All Stories

  1. CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy

    Article • Current Medicinal Chemistry, April 2024, Bentham Science Publishers

    Dr Xingang Guan

  2. Engineering SIRPα cellular membrane-based nanovesicles for combination immunotherapy

    Article • Nano Research, January 2023, Tsinghua University Press

    Dr Xingang Guan, Zhigang Xie

  3. Target Delivery of Daunorubicin to Glioblastoma by Cyclic RGD-Linked PEG-PLA Micelles

    Article • Journal of Macromolecular Science Part A, April 2015, Taylor & Francis

    Dr Xingang Guan